Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Update on the immunology, diagnosis and management of systemic lupus erythematosus

Identifieur interne : 001F35 ( Main/Exploration ); précédent : 001F34; suivant : 001F36

Update on the immunology, diagnosis and management of systemic lupus erythematosus

Auteurs : G. E. M. Reeves [Australie]

Source :

RBID : ISTEX:F127BD440A80F2FA392B8E6A236AF2BCBB055835

English descriptors

Abstract

Abstract Lupus occurs with a prevalence of 2−9 in 10 000 people, targeting female and indigenous populations in particular. Lupus and related systemic autoimmune syndromes (scleroderma, Sjögren's syndrome, rheumatoid arthritis and polymyositis) result from a similar set of genetically and environmentally modulated immune disturbances, and the diagnostic and management approach to these conditions is broadly comparable. Evanescent , vague symptoms, restrictive diagnostic criteria and low diagnostic suspicion might have resulted in the under‐diagnosis of these problems in the past, imposing considerable burdens on sufferers and the community. Serological screening should be employed cautiously and wisely, given the rapidly occurring changes in methodology, which have lowered their specificity. Close liaison with the immunology laboratories performing these tests is therefore advisable. Clinicians should emphasize the improving prognosis of lupus and related conditions as a result of earlier disease detection, improved educational support systems and refined medical therapies. (Intern Med J 2004: 34: 338−347)

Url:
DOI: 10.1111/j.1444-0903.2004.00578.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Update on the immunology, diagnosis and management of systemic lupus erythematosus</title>
<author>
<name sortKey="Reeves, G E M" sort="Reeves, G E M" uniqKey="Reeves G" first="G. E. M." last="Reeves">G. E. M. Reeves</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F127BD440A80F2FA392B8E6A236AF2BCBB055835</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1111/j.1444-0903.2004.00578.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-DPH4BK80-H/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000E18</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E18</idno>
<idno type="wicri:Area/Istex/Curation">000E18</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D76</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D76</idno>
<idno type="wicri:doubleKey">1444-0903:2004:Reeves G:update:on:the</idno>
<idno type="wicri:Area/Main/Merge">001F50</idno>
<idno type="wicri:Area/Main/Curation">001F35</idno>
<idno type="wicri:Area/Main/Exploration">001F35</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Update on the immunology, diagnosis and management of systemic lupus erythematosus</title>
<author>
<name sortKey="Reeves, G E M" sort="Reeves, G E M" uniqKey="Reeves G" first="G. E. M." last="Reeves">G. E. M. Reeves</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Immunology and Infectious Diseases, John Hunter Hospital, Newcastle, New South Wales</wicri:regionArea>
<wicri:noRegion>New South Wales</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Internal Medicine Journal</title>
<title level="j" type="alt">INTERNAL MEDICINE JOURNAL</title>
<idno type="ISSN">1444-0903</idno>
<idno type="eISSN">1445-5994</idno>
<imprint>
<biblScope unit="vol">34</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="338">338</biblScope>
<biblScope unit="page" to="347">347</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Blackwell Science Pty</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2004-06">2004-06</date>
</imprint>
<idno type="ISSN">1444-0903</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1444-0903</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Antinuclear</term>
<term>Antinuclear antibodies</term>
<term>Arthritis</term>
<term>Arthritis care</term>
<term>Arthritis rheum</term>
<term>Autoimmune</term>
<term>Autoimmune disease</term>
<term>Autoimmune diseases</term>
<term>Autoimmune disorders</term>
<term>Autoimmunity</term>
<term>Elisa</term>
<term>Erythematosus</term>
<term>Extractable</term>
<term>Fibromyalgia</term>
<term>Immune</term>
<term>Immune response</term>
<term>Immune system</term>
<term>Immunology</term>
<term>Internal medicine journal</term>
<term>John hunter hospital</term>
<term>Lupus</term>
<term>Lupus erythematosus</term>
<term>Major histocompatibility</term>
<term>Pharmacia australia</term>
<term>Rash</term>
<term>Reeves table</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatology</term>
<term>Serological screening</term>
<term>Smith antibody</term>
<term>Syndrome</term>
<term>Syndrome antibody</term>
<term>Systemic</term>
<term>Systemic lupus erythematosus</term>
<term>Test results</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract Lupus occurs with a prevalence of 2−9 in 10 000 people, targeting female and indigenous populations in particular. Lupus and related systemic autoimmune syndromes (scleroderma, Sjögren's syndrome, rheumatoid arthritis and polymyositis) result from a similar set of genetically and environmentally modulated immune disturbances, and the diagnostic and management approach to these conditions is broadly comparable. Evanescent , vague symptoms, restrictive diagnostic criteria and low diagnostic suspicion might have resulted in the under‐diagnosis of these problems in the past, imposing considerable burdens on sufferers and the community. Serological screening should be employed cautiously and wisely, given the rapidly occurring changes in methodology, which have lowered their specificity. Close liaison with the immunology laboratories performing these tests is therefore advisable. Clinicians should emphasize the improving prognosis of lupus and related conditions as a result of earlier disease detection, improved educational support systems and refined medical therapies. (Intern Med J 2004: 34: 338−347)</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Reeves, G E M" sort="Reeves, G E M" uniqKey="Reeves G" first="G. E. M." last="Reeves">G. E. M. Reeves</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F35 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001F35 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F127BD440A80F2FA392B8E6A236AF2BCBB055835
   |texte=   Update on the immunology, diagnosis and management of systemic lupus erythematosus
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021